ANTI-TUBERCULAR ACTIVITY OF EXTRACT AND COUMPOUNDS OF NONI (MORINDA CITRIFOLIA LINN)
DOI:
https://doi.org/10.22159/ijpps.2017v9i12.19841Keywords:
Morinda citrifolia Linn, Anti-tubercular activity, Flavonoids, Scopoletin, Alkaloids, AnthraquinonesAbstract
Objective: This study aimed to evaluate the antitubercular activity of extracts and compounds isolated of Morinda citrofolia Linn (noni) against Mycobacterium tuberculosis strains (H37Rv) with a dose of 10 mg/ml, 20 mg/ml, 30 mg/ml and 40 mg/ml.
Â
Methods: The noni fruits was extracted using 96% ethanol. A crude ethanol extract of noni tested by phytochemical fractionation to obtain flavonoids, alkaloids, scopoletin, and anthraquinone. Extract and active compounds of noni testing antibacterial activity against tuberculosis (H37RV) bacterial with a dose of 10 mg / ml, 20 mg / ml, 30 mg / ml and 40 mg / ml. This study was performed in vitro with laboratory-based experimental study. Statistical analysis was performed by analysis of variance.
Results: Compounds of noni shown to have antitubercular activity in inhibiting the growth of MDR TB bacteria at various doses compared to controls (p = 0.00). The mean number of bacterial colonies on the MDR TB crude ethanol extract (59.0± 60.51), alkaloids (64.8 ± 49.36), anthraquinone (69.5 ± 50.40), flavonoids (72.9 ± 58.7), scopoletin (95.9 ± 33.3) and negative controls (189.3 ± 35.19). Crude extract, alkaloids, anthraquinones, and flavonoid have highly bactericidal inhibition than scopoletin and negative control. The exhibited minimum inhibitory concentration (MIC) against M. Tuberculosis on the compound of the noni fruit is at a dose of 40 mg / ml
 Conclusion: All compounds and extract of noni fruits represents a potent active anti-TB against M. tuberculosis strains. An crude extract of noni was the most active compound against M. tuberculosis strains (H37RV).
Â
Downloads
References
World Health Organization. Global tuberculosis report. Switzerland; 2016.
World Health Organization. Tuberculosis profile. Switzerland; 2016.
World Health Organization. Treatment guidelines for drug-resistant tuberculosis. Switzerland; 2016.
World Health Organization. Companion handbook: to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Switzerland; 2016.
Motshakeri M, Ghazali HM. Nutritional, phytochemical and commercial quality of noni fruit: A multi-beneficial gift from nature. Trends Food Sci Technol 2015;45:118-29.
Haque M, Rao USM. Modulatory effect of noni fruit on the activities of key enzymes of glucose synthesis and utilization pathways of diabetic induced rats. J Pharm Res 2013;7:53-61.
Pandy V, Narasingam M, Kunasegaran T, Murugan DD, Mohamed Z. Effect of noni (Morinda citrifolia Linn.) fruit and its bioactive principles scopoletin and rutin on rat vas deferens contractility: an ex vivo study. Sci World J 2014:1-11. Doi:10.1155/2014/909586
Singh DR. Morinda citrifolia L. (Noni): a review of the scientific validation for its nutritional and therapeutic properties. J Diabetes Endocrinal 2012;3;6:77-91.
Gupta RK, Patel AK. Do the health claims made for Morinda citrifolia Linn (Noni) harmonize with current scientific knowledge and evaluation of its biological effects. Asian Pac J Cancer Prev 2014;8:4495-9.
Antara NS, Prabanca VG, Ekawati IGA. Antimikrobia activity of extracts noni (Morinda citrifolia L.) fruit against pathogen bacteria. Media Ilmiah Teknol Pangan 2014;1:1-9.
Usha R, Sashidharan S, Palaniswamy M. Antimicrobial activity of a rarely known species, Morinda citrifolia L. Ethnobotanical Leaflets 2010;14:306-11.
West BJ, Palmer SK, Deng S, Palu AK. Antimicrobial activity of an Iridoid rich extract from Morinda citrifolia fruit. Curr Res J Biol Sci 2012;4:52–4.
Saludes JP, Garson MJ, Franzblau SG, Aguinaldo AM. Anti-tubercular constituents from the hexane fraction of Morinda citrifolia Linn (Rubiaceae). Phytoher Res 2002;16:683-6.
Tuntun M, Andriansjah, Mun’im A. Susceptibility testing of MDR-TB and XDR-TB to noni fruit ethanol extract (Morinda citrofilia L), red ginger (Zingiber officunale R) aA/Mnd combination of both. J Bahan Alam Indonesia 2011;7:355-8.
Markandeyan D, Santhalingam K, Kannaiyan S, Suresh S, Paul B. Virtual screening of phytochemicals of Morinda citrifolia as anti-alzheimer agents using molegro virtual docker on p38α mitogen-activated protein kinase enzyme. Asian J Pharm Clin Res 2015;8:141-5.
Sathishkumar G, Gobinath C, Karpagam K, Hemamalini V, Premkumar K, Sivaramakrishnan S. Phyto-synthesis of silver nanoscale particles using Morinda citrifolia L. and its inhibitory activity against human pathogens. Colloids Surf B 2012;95:235-40.
Deng S, West BJ, Jensen CJ. A quantitative comparison of phytochemical components in global noni fruits and their commercial products. Food Chem 2010;122:267-70.
Pawlus AD, Kinghorn AD. Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia L. (noni). J Pharm Pharmacol 2007;59 Suppl 1:1587-609.
Anwar K, Triyasmono L. The compound of total phenolic, total flavonoid, and the antioxidant activity of ethaol extract of noni fruits (Morinda citrifolia L.). J Pharmasci 2016;3:83-92.
Martins D, Nunez CV. Secondary metabolites from Rubiaceae species. Molecules 2015;20:13422-95.
Ramamoorthy SP, Manickam D, Subramaniam S, Subramaniam S. Standardization and phytochemical screening of traditional formulation. Int J Curr Pharm Res 2017;1:70-4.
Brooks GF, Carroll KC. Mycobacteria. In: Medical Microbiology. 24th ed. Jawetz, Melnick, Adelberg’s. Eds. USA: The McGraw-Hill Companies, Inc; 2007. p. 320–31.
RÃos JL, Recio MC. Medicinal plants and antimicrobial activity. J Ethnol Pharmacol 2005;100:80–4.
Rogoza LN, Salakhutdinov NF, Tolstikov GA. Anti-tuberculosis activity of natural products: recent developments. Chemistry for sustainable developments 2011;661:103-20.
Nugrahaeni DK, Hadisaputro S, Suwondo A, Dharmana A. The effect of alpha-mangostin in balancing the ratio of cytokines pro-and anti-inflammation gamma (IFN-γ/IL-10) and severity of the disease in mice infected with Mycobacterium tuberculosis multidrug-resistant. Asian J Pharm Clin Res 2016;9 Suppl 2:273-7.
Malinggas F, Pangamanan DHC, Mariati NW. The inhibition power from noni fruit extract (Morinda citrifolia L) to Streptococcus mutant’s growth. Pharmacon J Ilm Farm Unsrat 2015;4:2302-493.
Dewi N. The usefulness and mechanism of noni fruit as therapy of the diseases. Yogyakarta Pustaka Baru Press; 2012.
Potterat O, Hamburger M. Morinda citrifolia (Noni) fruit-phytochemistry, pharmacology, safety. Planta Med 2007; 73:191–9.
George SA, Bhadran S, Sudhakar M, Harini. Comprehensive in vitro evaluation of pharmacological activities of selected plant extracts and gas chromatograph y-mass spectrometry profiling of flacourtia jangomas flower extract. Asian J Pharm Clin Res 2017;10:23744.
Arya V. A review on anti-tubercular plants. Int J Pharm Tech Res 2011;3:872-80.
Hossain MA, Al Kalbani MS, Al Farsi SAJ, Weli AM, Al-Riyami Q. Comparative study of total phenolics, flavonoids contents and evaluation of antioxidant and antimicrobial activities of different polarities fruits crude extracts of Datura metel L. Asian Pacific J Trop Dis 2014;4:383–8.
Kishore N, Mishra BB, Tripathi V, Tiwari VK. Alkaloids as potential anti-tubercular agents. Fitoterapia 2009;80:140-63.
Fouotsa H, Mbaveng AT, Mbazoa CD, Nkengfack AE, Farzana S, Iqbal CM, et al. Antibacterial constituents of three Cameroonian medicinal plants: Garcinia nobilis, Oricia suaveolens and Balsamocitrus camerunensis. BMC Complement Altern Med 2013;13:10-1.
Duraipandiyan V, Al-Dhabi NA, Ignacimuthu S. New antimicrobial anthraquinone 6,61-bis (1,5,7-trihydroxy-3-hydroxymethylanthraquinone) isolated from Streptomyces sp. isolate ERI-26. Saudi J Biol Sci 2016;23:731–5.
Bao L, Qin L, Liu L, Wu Y, Han T, Xue L, et al. Anthraquinone compounds from Morinda officinalis inhibits osteoclastic bone resorption in vitro. Chem Biol Interact 2011;194:97-105.
Published
How to Cite
Issue
Section
